Cynata Therapeutics Ltd has released a press release.
Cynata Prepares for Phase 1 Clinical Trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- Cynata Enters Agreement with apceth GmbH & Co KG
- CYP Manufactures CT Product-Files Further Patent Application
- Decision to Grant Patent for Cymerus MSC Technology in Japan
- Cynata & Regience Extend Entitlement Period
- Compelling Results from Pre-Clinical Stem Cell Study in GvHD
Later from Cynata Therapeutics
- Cynata Receives Investment Offer from Regience
- Cynata Files Application to Commence Phase 1 Clinical Trial
- CYP & FUJIFILM Sign Non-Binding Terms Sheet
- CYP Determines not to proceed with Regience Investment Offer
- UK Regulatory Authority Approves Cynata GvHD Clinical Trial
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics